Acelyrin Statistics
Total Valuation
Acelyrin has a market cap or net worth of $227.15 million. The enterprise value is -$174.36 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Acelyrin has 100.95 million shares outstanding. The number of shares has increased by 11.59% in one year.
| Current Share Class | 100.95M |
| Shares Outstanding | 100.95M |
| Shares Change (YoY) | +11.59% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 3.11% |
| Owned by Institutions (%) | 65.61% |
| Float | 68.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.43, with a Debt / Equity ratio of 0.02.
| Current Ratio | 18.43 |
| Quick Ratio | 17.81 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.08% and return on invested capital (ROIC) is -31.91%.
| Return on Equity (ROE) | -51.08% |
| Return on Assets (ROA) | -29.82% |
| Return on Invested Capital (ROIC) | -31.91% |
| Return on Capital Employed (ROCE) | -65.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.24M |
| Employee Count | 83 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.29% in the last 52 weeks. The beta is 1.09, so Acelyrin's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -48.29% |
| 50-Day Moving Average | 2.43 |
| 200-Day Moving Average | 3.65 |
| Relative Strength Index (RSI) | 47.51 |
| Average Volume (20 Days) | 1,091,351 |
Short Selling Information
The latest short interest is 3.57 million, so 3.54% of the outstanding shares have been sold short.
| Short Interest | 3.57M |
| Short Previous Month | 3.69M |
| Short % of Shares Out | 3.54% |
| Short % of Float | 5.21% |
| Short Ratio (days to cover) | 3.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -270.55M |
| Pretax Income | -240.16M |
| Net Income | -268.52M |
| EBITDA | -270.06M |
| EBIT | -270.55M |
| Earnings Per Share (EPS) | -$2.69 |
Full Income StatementBalance Sheet
The company has $410.59 million in cash and $7.07 million in debt, giving a net cash position of $403.52 million or $4.00 per share.
| Cash & Cash Equivalents | 410.59M |
| Total Debt | 7.07M |
| Net Cash | 403.52M |
| Net Cash Per Share | $4.00 |
| Equity (Book Value) | 407.23M |
| Book Value Per Share | 4.04 |
| Working Capital | 406.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$285.58 million and capital expenditures -$1.19 million, giving a free cash flow of -$286.77 million.
| Operating Cash Flow | -285.58M |
| Capital Expenditures | -1.19M |
| Free Cash Flow | -286.77M |
| FCF Per Share | -$2.84 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |